Certification de la chaîne du froid pharmaceutique: UN 2025 Guide
Certification de la chaîne du froid pharmaceutique: UN 2025 Guide Pharmaceutical cold chain certification ensures that temperaturesensitive medicines are stored and transported safely from the factory to the patient. Without rigorous certification, jusqu'à 20 % of temperaturesensitive healthcare products can be damaged during distribution, autour 30 % des expéditions subissent des écarts de température, and nearly half of vaccines are wasted. The global biopharmaceutical cold chain market is expected to surpass US$65 billion by 2025, making compliance more critical than ever. This article explains the importance of certification, the regulations and standards shaping the landscape in 2025, and practical steps to achieve and maintain compliance. Why pharmaceutical cold chain certification is vital for patient safety and product integrity in 2025, including statistics on product loss and waste. Which regulatory frameworks and standards govern cold chain certification in 2025, covering DSCSA, FSMA, I PIB, WHO guidelines and ISO standards. What certification programs exist for pharmaceutical cold chains and how they compare, such as CEIV Pharma, Certicold Pharma, NABP accreditation...